Dr. German joined the faculty at the Department of Pharmaceutical Sciences at TTUHSC in August 2014. She obtained her PhD in Medicinal and Natural Products Chemistry at the University of Iowa with Dr.R. Kerns, where she worked on synthesis of chemical probes designed to overcome bacterial resistance to antibiotics. This work resulted in discovering of novel inhibitor NorA and MepA efflux pumps as one of the most potent compounds to date. In 2007, Dr. German joined research group of Dr. R. Glennon at Virginia Commonwealth University as a postdoctoral fellow where she continued her medicinal chemistry-based research in the area of allosteric modulation of nicotinic receptors. In 2010, she continued her training at RTI International working with Dr. Y. Zhang on design and synthesis of various ligands for CNS receptors.

Interests

Addiction
Biochemistry
Breast health/cancer
Cancer
Depression
Drugs
Infectious disease
Lung cancer
Microbiology
Multiple sclerosis
Oncology
Pain
Parkinson's disease
Pharmacology
Research
Stroke
Women's health

Pharmacy Research Interests

LC-MS/MS, LC-UV/VIS, LC-ECD, UPLC-MS/MS
antimicrobial
cancer chemotherapy
chemistry
chemo-prevention
chemotherapy
disease state prevention
drug development
drug discovery
drug toxicity
invitro
medicinal chemistry
neuroinflammatory disease

Driven by a Mission

Driven by a Mission

Driven by a Mission

Driven by a Mission

Driven by a Mission

Driven by a Mission

Driven by a Mission

Driven by a Mission

Driven by a Mission

Driven by a Mission

Nadia Anatolyevna German

Contact